Abstract |
A randomized, double-blind, multicentre study was conducted in adult patients with acute exacerbation of chronic bronchitis (AECB), to compare the efficacy of a 5-day course of levofloxacin 500 mg once daily, with the standard 7-day regimen at the same dose. Five hundred and thirty-two patients from 48 centres in 10 countries were randomized to receive levofloxacin: 268 and 264 received the 5- and 7-day courses, respectively. The primary efficacy analysis was the clinical response at 7-10 days post-treatment in the per-protocol (PP) population. Clinical success rates in the primary PP analysis of 482 patients were 82.8% (197/238) for the 5-day group and 84.8% (207/244) for the 7-day group. The difference in success rates was -2.1% with a 95% CI of (-9.1 to 4.9%). The bacteriological response showed eradication rates of 82.1% (92/112) and 83.2% (84/101) in the 5- and 7-day groups, respectively. Both treatments were well tolerated. These results show that for patients with AECB levofloxacin 500 mg once daily for 5 days provides equivalent clinical and bacteriological success to the same dose given for 7 days irrespective of the patient's age, the frequency of exacerbations or the presence of co-existing cardiopulmonary or chronic obstructive airways disease.
|
Authors | R G Masterton, C J Burley |
Journal | International journal of antimicrobial agents
(Int J Antimicrob Agents)
Vol. 18
Issue 6
Pg. 503-12
(Dec 2001)
ISSN: 0924-8579 [Print] Netherlands |
PMID | 11738336
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Infective Agents
- Levofloxacin
- Ofloxacin
|
Topics |
- Acute Disease
- Administration, Oral
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Anti-Infective Agents
(administration & dosage, therapeutic use)
- Bronchitis, Chronic
(drug therapy)
- Double-Blind Method
- Drug Administration Schedule
- Female
- Humans
- Levofloxacin
- Male
- Middle Aged
- Ofloxacin
(administration & dosage, therapeutic use)
- Treatment Outcome
|